A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors

Abstract Identifying women at high risk of osteoporotic fracture from aromatase inhibitor (AI) therapy for breast cancer is largely based on known risk factors for healthy postmenopausal women, which might not accurately reflect the risk in breast cancer patients post-AI therapy. To determine whethe...

Descrición completa

Detalles Bibliográficos

Principais autores:	Christine Hook, Udit Chatterjee, Haiyang Sheng, Qianqian Zhu, Timothy Robinson, Janise M. Roh, Cecile A. Laurent, Catherine Lee, Jennifer Delmerico, Joan C. Lo, Christine B. Ambrosone, Lawrence H. Kushi, Marilyn L. Kwan, Song Yao
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Portfolio 2024-01-01
Series:	npj Breast Cancer
Acceso en liña:	https://doi.org/10.1038/s41523-024-00615-9
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!